Finding 1158168 (2024-001)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-09-30
Audit: 370077
Organization: The Scintillon Institute (CA)
Auditor: Leaf & Cole LLP

AI Summary

  • Issue: The Institute drew down funds beyond the recommended three-day period, violating cash management guidelines.
  • Requirements Impacted: Non-compliance with 2 CFR 215.22, which mandates minimizing the time between fund transfers and payments.
  • Recommended Follow-Up: Enhance cash management policies to ensure accurate calculations for immediate cash needs and compliance by 2025.

Finding Text

Condition Funds were drawn down by the Institute in excess of the three-day period recommended by its funding agency, and did not minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient during the year ended December 31, 2024. Criteria Cash management under 2 CFR 215.22 states that payment methods shall minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient. Cause The Institute’s preparation and review procedures over the draw-down of funds were insufficient to minimize the time elapsing between the transfers of funds from the grantor to the issue of payments by the Institute. Effect The Institute was not in compliance with the cash management compliance requirements stated in 2 CFR 215.22 during the year. Recommendation The Institute should improve policies and procedures regarding cash management. This should include the procedure for calculating the allowable cash draw for actual immediate cash needs for expenses to be paid within the three-day period, in order to minimize the time elapsing between the transfer of funds from the grantor to the issue of payment by the recipient to cover operating cash flow needs. Views of Responsible Officials and Planned Corrective Actions Management acknowledges the finding and the management staff of the Institute take seriously the federal compliance requirements that apply to drawing funds from the DHHS Payment Management System. The Institute recognizes that it has drawn down excess funds. The Institute plans to improve policies and procedures for cash management in 2025 that will ensure the calculation for allowable cash draw for actual immediate cash needs is complete and accurate.

Corrective Action Plan

Condition Funds were drawn down by the Institute in excess of the three-day period recommended by its funding agency and did not minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient during the year ended December 31, 2024. Management Response Management acknowledges the finding and the management staff of the Institute take seriously the federal compliance requirements that apply to drawing funds from the DHHS Payment Management System. The Institute recognizes that it has drawn down excess funds. The Institute plans to improve policies and procedures for cash management in 2025 that will ensure the calculation for allowable cash draw for actual immediate cash needs is complete and accurate. Action Taken Scintillon plans to improve policies and procedures for cash management in 2025 that will ensure the calculation for allowable cash draw for actual immediate cash needs is complete and accurate.

Categories

Cash Management

Other Findings in this Audit

  • 1158152 2024-001
    Material Weakness Repeat
  • 1158153 2024-001
    Material Weakness Repeat
  • 1158154 2024-001
    Material Weakness Repeat
  • 1158155 2024-001
    Material Weakness Repeat
  • 1158156 2024-001
    Material Weakness Repeat
  • 1158157 2024-001
    Material Weakness Repeat
  • 1158158 2024-001
    Material Weakness Repeat
  • 1158159 2024-001
    Material Weakness Repeat
  • 1158160 2024-001
    Material Weakness Repeat
  • 1158161 2024-001
    Material Weakness Repeat
  • 1158162 2024-001
    Material Weakness Repeat
  • 1158163 2024-001
    Material Weakness Repeat
  • 1158164 2024-001
    Material Weakness Repeat
  • 1158165 2024-001
    Material Weakness Repeat
  • 1158166 2024-001
    Material Weakness Repeat
  • 1158167 2024-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $982,724
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $437,876
93.837 Cardiovascular Diseases Research $218,316
93.113 Environmental Health $212,011
93.173 Research Related to Deafness and Communication Disorders $211,344
93.866 Aging Research $72,893
93.396 Cancer Biology Research $70,434
12.420 Military Medical Research and Development $68,723
93.395 Cancer Treatment Research $57,605
93.859 Biomedical Research and Research Training $42,515
93.310 Trans-Nih Research Support $1,064
93.855 Allergy and Infectious Diseases Research $-8,042